跳至主要内容
临床试验/CTRI/2009/091/000490
CTRI/2009/091/000490已完成4 期

The Impact of Regular Usage of Paracetamol at Therapeutic Doses on Bronchial-Hyper-responsiveness and Lung Functions in the Asthmatic Subjects

il0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ?Mild- to-moderate asthmatics in accordance with the GINA guidelines
  • ? Male and females18?70 years old
  • ?Baseline FEV1 ≥60% predicted
  • ?PC20 methacholine of ≤8.0 mg/ml

排除标准

  • ?Subjects with aspirin induced asthma
  • ?Asthmatics with exacerbation of asthma within the previous three months requiring oral steroids, nebulised bronchodilator, antibiotics or an emergency visit to the doctor
  • ?Current or past cigarette smoking >10 pack years
  • ?History of allergy or sensitivity to paracetamol, aspirin or ibuprofen
  • ?Current or past history of liver disease or on potentially hepatotoxic drugs
  • ?Deranged liver function, signified by elevated enzyme levels
  • ?Current regular use of paracetamol
  • ?History of alcoholism, or current excessive alcohol intake
  • ?Previous intentional acute overdose of paracetamol, previous suicide attempt or current depression
  • ?Evidence of malnutrition or BMI <20 kg/m2
  • ?Women of child-bearing age not using adequate contraception

研究者

发起方
il

相似试验